Publications

Jump below to

2011–Now

  1. Yee SW, Stecula A, Chien HC, Zou L, Feofanova EV, van Borselen M, Cheung KWK, Yousri NA, Suhre K, Kinchen JM, Boerwinkle E, Irannejad R, Yu B, Giacomini KM11. Unraveling the functional role of the orphan solute carrier, SLC22A24 in the transport of steroid conjugates through metabolomic and genome-wide association studies. PLoS Genet. 2019 Sep; 15(9):e1008208. PMID: 31553721. View in: PubMed12

  2. Lang S, Hilsabeck TA, Wilson KA, Sharma A, Bose N, Brackman DJ, Beck JN, Chen L, Watson MA, Killilea DW, Ho S, Kahn A, Giacomini KM11, Stoller ML, Chi T, Kapahi P. A conserved role of the insulin-like signaling pathway in diet-dependent uric acid pathologies in Drosophila melanogaster. PLoS Genet. 2019 Aug; 15(8):e1008318. PMID: 31415568. View in: PubMed13

  3. Cheung KWK, van Groen BD, Spaans E, van Borselen MD, de Bruijn ACJM, Simons-Oosterhuis Y, Tibboel D, Samsom JN, Verdijk RM, Smeets B, Zhang L, Huang SM, Giacomini KM11, de Wildt SN. A Comprehensive Analysis of Ontogeny of Renal Drug Transporters: mRNA Analyses, Quantitative Proteomics, and Localization. Clin Pharmacol Ther. 2019 Nov; 106(5):1083-1092. PMID: 31127606. View in: PubMed14

  4. Hall C, Wolfe H, Wells A, Chien HC, Colas C, Schlessinger A, Giacomini KM11, Thomas AA. l-Type amino acid transporter 1 activity of 1,2,3-triazolyl analogs of l-histidine and l-tryptophan. Bioorg Med Chem Lett. 2019 Aug 15; 29(16):2254-2258. PMID: 31248771. View in: PubMed15

  5. Brackman DJ, Yee SW, Enogieru OJ, Shaffer C, Ranatunga D, Denny JC, Wei WQ, Kamatani Y, Kubo M, Roden DM, Jorgenson E, Giacomini KM11. Genome-Wide Association and Functional Studies Reveal Novel Pharmacological Mechanisms for Allopurinol. Clin Pharmacol Ther. 2019 Sep; 106(3):623-631. PMID: 30924126. View in: PubMed16

  6. Enogieru OJ, Ung PMU, Yee SW, Schlessinger A, Giacomini KM11. Functional and structural analysis of rare SLC2A2 variants associated with Fanconi-Bickel syndrome and metabolic traits. Hum Mutat. 2019 Jul; 40(7):983-995. PMID: 30950137. View in: PubMed17

  7. Yee SW, Giacomini MM, Shen H, Humphreys WG, Horng H, Brian W, Lai Y, Kroetz DL, Giacomini KM11. Organic Anion Transporter Polypeptide 1B1 Polymorphism Modulates the Extent of Drug-Drug Interaction and Associated Biomarker Levels in Healthy Volunteers. Clin Transl Sci. 2019 Jul; 12(4):388-399. PMID: 30982223. View in: PubMed18

  8. Giacomini KM11, Lin L, Altman RB. Research Projects Supported by the University of California, San Francisco-Stanford Center of Excellence in Regulatory Science and Innovation. Clin Pharmacol Ther. 2019 Apr; 105(4):815-818. PMID: 30773618. View in: PubMed19

  9. Zou L, Ni Z, Tsakalozou E, Giacomini KM11. Impact of Pharmaceutical Excipients on Oral Drug Absorption: A Focus on Intestinal Drug Transporters. Clin Pharmacol Ther. 2019 Feb; 105(2):323-325. PMID: 30663035. View in: PubMed20

  10. Song W, Luo Q, Zhang Y, Zhou L, Liu Y, Ma Z, Guo J, Huang Y, Cheng L, Meng Z, Li Z, Zhang B, Li S, Yee SW, Fan H, Li P, Giacomini KM11, Chen L. Organic cation transporter 3 (Oct3) is a distinct catecholamines clearance route in adipocytes mediating the beiging of white adipose tissue. PLoS Biol. 2019 01; 17(1):e2006571. PMID: 30653498. View in: PubMed21

  11. Chu X, Liao M, Shen H, Yoshida K, Zur AA, Arya V, Galetin A, Giacomini KM11, Hanna I, Kusuhara H, Lai Y, Rodrigues D, Sugiyama Y, Zamek-Gliszczynski MJ, Zhang L. Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug-Drug Interaction Evaluation: Perspectives From the International Transporter Consortium. Clin Pharmacol Ther. 2018 11; 104(5):836-864. PMID: 30347454. View in: PubMed22

  12. Giacomini KM11, Galetin A, Huang SM. The International Transporter Consortium: Summarizing Advances in the Role of Transporters in Drug Development. Clin Pharmacol Ther. 2018 11; 104(5):766-771. PMID: 30137696. View in: PubMed23

  13. Chien HC, Colas C, Finke K, Springer S, Stoner L, Zur AA, Venteicher B, Campbell J, Hall C, Flint A, Augustyn E, Hernandez C, Heeren N, Hansen L, Anthony A, Bauer J, Fotiadis D, Schlessinger A, Giacomini KM11, Thomas AA. Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1). J Med Chem. 2018 08 23; 61(16):7358-7373. PMID: 30048132. View in: PubMed24

  14. Zamek-Gliszczynski MJ, Taub ME, Chothe PP, Chu X, Giacomini KM11, Kim RB, Ray AS, Stocker SL, Unadkat JD, Wittwer MB, Xia C, Yee SW, Zhang L, Zhang Y. Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance. Clin Pharmacol Ther. 2018 11; 104(5):890-899. PMID: 30091177. View in: PubMed25

  15. Yee SW, Brackman DJ, Ennis EA, Sugiyama Y, Kamdem LK, Blanchard R, Galetin A, Zhang L, Giacomini KM11. Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium. Clin Pharmacol Ther. 2018 11; 104(5):803-817. PMID: 29679469. View in: PubMed26

  16. Zamek-Gliszczynski MJ, Chu X, Cook JA, Custodio JM, Galetin A, Giacomini KM11, Lee CA, Paine MF, Ray AS, Ware JA, Wittwer MB, Zhang L. ITC Commentary on Metformin Clinical Drug-Drug Interaction Study Design That Enables an Efficacy- and Safety-Based Dose Adjustment Decision. Clin Pharmacol Ther. 2018 11; 104(5):781-784. PMID: 29761830. View in: PubMed27

  17. Srinivasan S, Yee SW, Giacomini KM11. Pharmacogenetics of Antidiabetic Drugs. Adv Pharmacol. 2018; 83:361-389. PMID: 29801583. View in: PubMed28

  18. Zou L, Stecula A, Gupta A, Prasad B, Chien HC, Yee SW, Wang L, Unadkat JD, Stahl SH, Fenner KS, Giacomini KM11. Molecular Mechanisms for Species Differences in Organic Anion Transporter 1, OAT1: Implications for Renal Drug Toxicity. Mol Pharmacol. 2018 07; 94(1):689-699. PMID: 29720497. View in: PubMed29

  19. Liang X, Yee SW, Chien HC, Chen EC, Luo Q, Zou L, Piao M, Mifune A, Chen L, Calvert ME, King S, Norheim F, Abad J, Krauss RM, Giacomini KM11. Organic cation transporter 1 (OCT1) modulates multiple cardiometabolic traits through effects on hepatic thiamine content. PLoS Biol. 2018 04; 16(4):e2002907. PMID: 29659562. View in: PubMed30

  20. Rotroff DM, Yee SW, Zhou K, Marvel SW, Shah HS, Jack JR, Havener TM, Hedderson MM, Kubo M, Herman MA, Gao H, Mychaleckyi JC, McLeod HL, Doria A, Giacomini KM11, Pearson ER, Wagner MJ, Buse JB, Motsinger-Reif AA. Genetic Variants in CPA6 and PRPF31 Are Associated With Variation in Response to Metformin in Individuals With Type 2 Diabetes. Diabetes. 2018 07; 67(7):1428-1440. PMID: 29650774. View in: PubMed31

  21. Zamek-Gliszczynski MJ, Giacomini KM11, Zhang L. Emerging Clinical Importance of Hepatic Organic Cation Transporter 1 (OCT1) in Drug Pharmacokinetics, Dynamics, Pharmacogenetic Variability, and Drug Interactions. Clin Pharmacol Ther. 2018 05; 103(5):758-760. PMID: 29193038. View in: PubMed32

  22. Brackman DJ, Giacomini KM11. Reverse Translational Research of ABCG2 (BCRP) in Human Disease and Drug Response. Clin Pharmacol Ther. 2018 02; 103(2):233-242. PMID: 29023674. View in: PubMed33

  23. Fohner AE, Brackman DJ, Giacomini KM11, Altman RB, Klein TE. PharmGKB summary: very important pharmacogene information for ABCG2. Pharmacogenet Genomics. 2017 11; 27(11):420-427. PMID: 28858993. View in: PubMed34

  24. Relling MV, Krauss RM, Roden DM, Klein TE, Fowler DM, Terada N, Lin L, Riel-Mehan M, Do TP, Kubo M, Yee SW, Johnson GT, Giacomini KM11. New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine. Clin Pharmacol Ther. 2017 Dec; 102(6):897-902. PMID: 28795399. View in: PubMed35

  25. Hsueh CH, Hsu V, Zhao P, Zhang L, Giacomini KM11, Huang SM. PBPK Modeling of the Effect of Reduced Kidney Function on the Pharmacokinetics of Drugs Excreted Renally by Organic Anion Transporters. Clin Pharmacol Ther. 2018 03; 103(3):485-492. PMID: 28738449. View in: PubMed36

  26. Stecula A, Schlessinger A, Giacomini KM11, Sali A. Human Concentrative Nucleoside Transporter 3 (hCNT3, SLC28A3) Forms a Cyclic Homotrimer. Biochemistry. 2017 07 11; 56(27):3475-3483. PMID: 28661652. View in: PubMed37

  27. Khuri N, Zur AA, Wittwer MB, Lin L, Yee SW, Sali A, Giacomini KM11. Computational Discovery and Experimental Validation of Inhibitors of the Human Intestinal Transporter OATP2B1. J Chem Inf Model. 2017 06 26; 57(6):1402-1413. PMID: 28562037. View in: PubMed38

  28. Liang X, Giacomini KM11. Transporters Involved in Metformin Pharmacokinetics and Treatment Response. J Pharm Sci. 2017 09; 106(9):2245-2250. PMID: 28495567. View in: PubMed39

  29. Cheung KWK, Hsueh CH, Zhao P, Meyer TW, Zhang L, Huang SM, Giacomini KM11. The Effect of Uremic Solutes on the Organic Cation Transporter 2. J Pharm Sci. 2017 09; 106(9):2551-2557. PMID: 28483424. View in: PubMed40

  30. Chen EC, Khuri N, Liang X, Stecula A, Chien HC, Yee SW, Huang Y, Sali A, Giacomini KM11. Discovery of Competitive and Noncompetitive Ligands of the Organic Cation Transporter 1 (OCT1; SLC22A1). J Med Chem. 2017 04 13; 60(7):2685-2696. PMID: 28230985. View in: PubMed41

  31. Dujic T, Zhou K, Yee SW, van Leeuwen N, de Keyser CE, Javorský M, Goswami S, Zaharenko L, Hougaard Christensen MM, Out M, Tavendale R, Kubo M, Hedderson MM, van der Heijden AA, Klimcáková L, Pirags V, Kooy A, Brøsen K, Klovins J, Semiz S, Tkác I, Stricker BH, Palmer C, 't Hart LM, Giacomini KM11, Pearson ER. Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta-Analysis. Clin Pharmacol Ther. 2017 Jun; 101(6):763-772. PMID: 27859023. View in: PubMed42

  32. Luizon MR, Eckalbar WL, Wang Y, Jones SL, Smith RP, Laurance M, Lin L, Gallins PJ, Etheridge AS, Wright F, Zhou Y, Molony C, Innocenti F, Yee SW, Giacomini KM11, Ahituv N. Genomic Characterization of Metformin Hepatic Response. PLoS Genet. 2016 Nov; 12(11):e1006449. PMID: 27902686. View in: PubMed43

  33. Giacomini KM11, Yee SW, Mushiroda T, Weinshilboum RM, Ratain MJ, Kubo M. Genome-wide association studies of drug response and toxicity: an opportunity for genome medicine. Nat Rev Drug Discov. 2017 Jan; 16(1):1. PMID: 27885282. View in: PubMed44

  34. Giacomini KM11. The use of drug transporters as therapeutic targets. Clin Adv Hematol Oncol. 2016 Nov; 14(11):869-871. PMID: 27930637. View in: PubMed45

  35. Irwin JJ, Pottel J, Zou L, Wen H, Zuk S, Zhang X, Sterling T, Shoichet BK, Lionberger R, Giacomini KM11. A Molecular Basis for Innovation in Drug Excipients. Clin Pharmacol Ther. 2016 Aug 24. PMID: 27557422.
    View in: PubMed46

  36. Hsueh CH, Yoshida K, Zhao P, Meyer TW, Zhang L, Huang SM, Giacomini KM47, et al. Identification and Quantitative Assessment of Uremic Solutes as Inhibitors of Renal Organic Anion Transporters, OAT1 and OAT3. Mol Pharm. 2016 Aug 9. PMID: 27467266.
    View in: PubMed48

  37. Zhou K, Yee SW, Seiser EL, van Leeuwen N, Tavendale R, Bennett AJ, Groves CJ, Coleman RL, van der Heijden AA, Beulens JW, de Keyser CE, Zaharenko L, Rotroff DM, Out M, Jablonski KA, Chen L, Javorský M, Židzik J, Levin AM, Williams LK, Dujic T, Semiz S, Kubo M, Chien HC, Maeda S, Witte JS, Wu L, Tkác I, Kooy A, van Schaik RH, Stehouwer CD, Logie L, Sutherland C, Klovins J, Pirags V, Hofman A, Stricker BH, Motsinger-Reif AA, Wagner MJ, Innocenti F, Hart LM, Holman RR, McCarthy MI, Hedderson MM, Palmer CN, Florez JC, Giacomini KM47, Pearson ER, et al. Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin. Nat Genet. 2016 Aug 8. PMID: 27500523.
    View in: PubMed49

  38. Yee SW, Giacomini MM, Hsueh CH, Weitz D, Liang X, Goswami S, Kinchen JM, Coelho A, Zur AA, Mertsch K, Brian W, Kroetz DL, Giacomini KM47, et al. Metabolomic and Genome-wide Association Studies Reveal Potential Endogenous Biomarkers for OATP1B1. Clin Pharmacol Ther. 2016 Jul 22. PMID: 27447836.
    View in: PubMed50

  39. Goswami S, Yee SW, Xu F, Sridhar SB, Mosley JJ, Takahashi A, Kubo M, Maeda S, Davis RL, Roden DM, Hedderson MM, Giacomini KM47, Savic RM, et al. A Longitudinal HbA1c Model Elucidates Genes Linked to Disease Progression on Metformin. Clin Pharmacol Ther. 2016 Jul 14. PMID: 27415606.
    View in: PubMed51

  40. Rotroff DM, Oki NO, Liang X, Yee SW, Stocker SL, Corum DG, Meisner M, Fiehn O, Motsinger-Reif AA, Giacomini KM47, Kaddurah-Daouk R. Pharmacometabolomic Assessment of Metformin in Non-diabetic, African Americans. Front Pharmacol. 2016; 7:135. PMID: 27378919.
    View in: PubMed52

  41. Yee SW, Momozawa Y, Kamatani Y, Tyndale RF, Weinshilboum RM, Ratain MJ, Giacomini KM47, Kubo M, et al. Genomewide Association Studies in Pharmacogenomics: Meeting Report of the NIH Pharmacogenomics Research Network-RIKEN (PGRN-RIKEN) Collaboration. Clin Pharmacol Ther. 2016 Jun 3. PMID: 27256705.
    View in: PubMed53

  42. Hibma JE, Zur AA, Castro RA, Wittwer MB, Keizer RJ, Yee SW, Goswami S, Stocker SL, Zhang X, Huang Y, Brett CM, Savic RM, Giacomini KM47. The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin. Clin Pharmacokinet. 2016 Jun; 55(6):711-21. PMID: 26597253.
    View in: PubMed54

  43. Temple W, Mendelsohn L, Kim GE, Nekritz E, Gustafson WC, Lin L, Giacomini K47, Naranjo A, Van Ryn C, Yanik GA, Kreissman SG, Hogarty M, Matthay KK, DuBois SG. Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group. Eur J Nucl Med Mol Imaging. 2016 Mar; 43(3):474-81. PMID: 26338179.
    View in: PubMed55

  44. Altman RB, Prabhu S, Sidow A, Zook JM, Goldfeder R, Litwack D, Ashley E, Asimenos G, Bustamante CD, Donigan K, Giacomini KM47, Johansen E, Khuri N, Lee E, Liang XS, Salit M, Serang O, Tezak Z, Wall DP, Mansfield E, Kass-Hout T. A research roadmap for next-generation sequencing informatics. Sci Transl Med. 2016 Apr 20; 8(335):335ps10. PMID: 27099173.
    View in: PubMed56

  45. Augustyn E, Finke K, Zur AA, Hansen L, Heeren N, Chien HC, Lin L, Giacomini KM47, Colas C, Schlessinger A, Thomas AA. LAT-1 activity of meta-substituted phenylalanine and tyrosine analogs. Bioorg Med Chem Lett. 2016 Jun 1; 26(11):2616-21. PMID: 27106710.
    View in: PubMed57

  46. Morrissey KM, Stocker SL, Chen EC, Castro RA, Brett CM, Giacomini KM47. The Effect of Nizatidine, a MATE2K Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin in Healthy Volunteers. Clin Pharmacokinet. 2016 Apr; 55(4):495-506. PMID: 26507723.
    View in: PubMed58

  47. Chhibber A, French CE, Yee SW, Gamazon ER, Theusch E, Qin X, Webb A, Papp AC, Wang A, Simmons CQ, Konkashbaev A, Chaudhry AS, Mitchel K, Stryke D, Ferrin TE, Weiss ST, Kroetz DL, Sadee W, Nickerson DA, Krauss RM, George AL, Schuetz EG, Medina MW, Cox NJ, Scherer SE, Giacomini KM47, Brenner SE. Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines. Pharmacogenomics J. 2016 Feb 9. PMID: 26856248.
    View in: PubMed59

  48. Chien HC, Zur AA, Maurer TS, Yee SW, Tolsma J, Jasper P, Scott DO, Giacomini KM47. Rapid Method To Determine Intracellular Drug Concentrations in Cellular Uptake Assays: Application to Metformin in Organic Cation Transporter 1-Transfected Human Embryonic Kidney 293 Cells. Drug Metab Dispos. 2016 Mar; 44(3):356-64. PMID: 26700958.
    View in: PubMed60

  49. Altman RB, Khuri N, Salit M, Giacomini KM47. Unmet needs: Research helps regulators do their jobs. Sci Transl Med. 2015 Nov 25; 7(315):315ps22. PMID: 26606966.
    View in: PubMed61

  50. Liang X, Chien HC, Yee SW, Giacomini MM, Chen EC, Piao M, Hao J, Twelves J, Lepist EI, Ray AS, Giacomini KM47. Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3). Mol Pharm. 2015 Dec 7; 12(12):4301-10. PMID: 26528626.
    View in: PubMed62

  51. Yee SW, Lin L, Merski M, Keiser MJ63, Gupta A, Zhang Y, Chien HC, Shoichet BK64, Giacomini KM47. Prediction and validation of enzyme and transporter off-targets for metformin. J Pharmacokinet Pharmacodyn. 2015 Oct; 42(5):463-75. PMID: 26335661; PMCID: PMC4656030.
    View in: PubMed65, PubMed Central66

  52. Lin L67, Yee SW, Kim RB, Giacomini KM47. SLC transporters as therapeutic targets: emerging opportunities. Nat Rev Drug Discov. 2015 Aug; 14(8):543-60. PMID: 26111766.
    View in: PubMed68

  53. Chen EC, Liang X, Yee SW, Geier EG69, Stocker SL, Chen L, Giacomini KM47. Targeted disruption of organic cation transporter 3 attenuates the pharmacologic response to metformin. Mol Pharmacol. 2015 Jul; 88(1):75-83. PMID: 25920679; PMCID: PMC4468641 [Available on 07/01/16].
    View in: PubMed70, PubMed Central71

  54. Wen CC, Yee SW, Liang X, Hoffmann TJ72, Kvale MN, Banda Y, Jorgenson E, Schaefer C, Risch N73, Giacomini KM47. Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response. Clin Pharmacol Ther. 2015 May; 97(5):518-25. PMID: 25676789; PMCID: PMC4479153.
    View in: PubMed74, PubMed Central75

  55. DuBois SG, Groshen S, Park JR, Haas-Kogan DA, Yang X, Geier E69, Chen E, Giacomini K, Weiss B, Cohn SL, Granger MM, Yanik GA, Hawkins R, Courtier J76, Jackson H, Goodarzian F, Shimada H, Czarnecki S, Tsao-Wei D, Villablanca JG, Marachelian A, Matthay KK77. Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma. Clin Cancer Res. 2015 Jun 15; 21(12):2715-21. PMID: 25695691; PMCID: PMC4470833 [Available on 06/15/16].
    View in: PubMed78, PubMed Central79

  56. Dahlin A, Wittwer M, de la Cruz M, Woo JM, Bam R, Scharen-Guivel V, Flaherty J, Ray AS, Cihlar T, Gupta SK, Giacomini KM47. A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndrome. Pharmacogenet Genomics. 2015 Feb; 25(2):82-92. PMID: 25485598; PMCID: PMC4331349 [Available on 02/01/16].
    View in: PubMed80, PubMed Central81

  57. Chen L, Yee SW, Giacomini KM47. OCT1 in hepatic steatosis and thiamine disposition. Cell Cycle. 2015; 14(3):283-4. PMID: 25590948; PMCID: PMC4353231 [Available on 02/01/16].
    View in: PubMed82, PubMed Central83

  58. Smith RP, Eckalbar WL84, Morrissey KM, Luizon MR, Hoffmann TJ72, Sun X, Jones SL, Force Aldred S, Ramamoorthy A, Desta Z, Liu Y, Skaar TC, Trinklein ND, Giacomini KM47, Ahituv N85. Genome-wide discovery of drug-dependent human liver regulatory elements. PLoS Genet. 2014 Oct; 10(10):e1004648. PMID: 25275310; PMCID: PMC4183418.
    View in: PubMed86, PubMed Central87

  59. Pawlyk AC, Giacomini KM47, McKeon C, Shuldiner AR, Florez JC88. Metformin pharmacogenomics: current status and future directions. Diabetes. 2014 Aug; 63(8):2590-9. PMID: 25060887; PMCID: PMC4113063.
    View in: PubMed89, PubMed Central90

  60. Chen L, Shu Y, Liang X, Chen EC, Yee SW, Zur AA, Li S, Xu L, Keshari KR, Lin MJ, Chien HC, Zhang Y, Morrissey KM, Liu J, Ostrem J, Younger NS, Kurhanewicz J91, Shokat KM92, Ashrafi K93, Giacomini KM47. OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin. Proc Natl Acad Sci U S A. 2014 Jul 8; 111(27):9983-8. PMID: 24961373; PMCID: PMC4103324.
    View in: PubMed94, PubMed Central95

  61. Goswami S, Gong L, Giacomini K47, Altman RB, Klein TE. PharmGKB summary: very important pharmacogene information for SLC22A1. Pharmacogenet Genomics. 2014 Jun; 24(6):324-8. PMID: 24681965; PMCID: PMC4035531.
    View in: PubMed96, PubMed Central97

  62. Goswami S, Yee SW, Stocker S, Mosley JD, Kubo M, Castro R, Mefford JA, Wen C, Liang X, Witte J98, Brett C99, Maeda S, Simpson MD, Hedderson MM, Davis RL, Roden DM, Giacomini KM47, Savic RM100. Genetic variants in transcription factors are associated with the pharmacokinetics and pharmacodynamics of metformin. Clin Pharmacol Ther. 2014 Sep; 96(3):370-9. PMID: 24853734; PMCID: PMC4171106.
    View in: PubMed101, PubMed Central102

  63. Clancy JP, Johnson SG, Yee SW, McDonagh EM, Caudle KE, Klein TE, Cannavo M, Giacomini KM47. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotype. Clin Pharmacol Ther. 2014 Jun; 95(6):592-7. PMID: 24598717; PMCID: PMC4026598.
    View in: PubMed103, PubMed Central104

  64. Hsu V, de L T Vieira M, Zhao P, Zhang L, Zheng JH, Nordmark A, Berglund EG, Giacomini KM47, Huang SM. Towards quantitation of the effects of renal impairment and probenecid inhibition on kidney uptake and efflux transporters, using physiologically based pharmacokinetic modelling and simulations. Clin Pharmacokinet. 2014 Mar; 53(3):283-93. PMID: 24214317; PMCID: PMC3927056.
    View in: PubMed105, PubMed Central106

  65. Drake KA, Torgerson DG, Gignoux CR, Galanter JM, Roth LA, Huntsman S, Eng C, Oh SS, Yee SW, Lin L, Bustamante CD, Moreno-Estrada A, Sandoval K, Davis A, Borrell LN, Farber HJ, Kumar R, Avila PC, Brigino-Buenaventura E, Chapela R, Ford JG, Lenoir MA, Lurmann F, Meade K, Serebrisky D, Thyne S, Rodríguez-Cintrón W, Sen S107, Rodríguez-Santana JR, Hernandez RD108, Giacomini KM47, Burchard EG. A genome-wide association study of bronchodilator response in Latinos implicates rare variants. J Allergy Clin Immunol. 2014 Feb; 133(2):370-8. PMID: 23992748; PMCID: PMC3938989.
    View in: PubMed109, PubMed Central110

  66. Geier EG69, Chen EC, Webb A, Papp AC, Yee SW, Sadee W, Giacomini KM47. Profiling solute carrier transporters in the human blood-brain barrier. Clin Pharmacol Ther. 2013 Dec; 94(6):636-9. PMID: 24013810; PMCID: PMC3906042.
    View in: PubMed111, PubMed Central112

  67. Schlessinger A, Yee SW, Sali A, Giacomini KM47. SLC classification: an update. Clin Pharmacol Ther. 2013 Jul; 94(1):19-23. PMID: 23778706; PMCID: PMC4068830.
    View in: PubMed113, PubMed Central114

  68. Giacomini KM47, Huang SM. Transporters in drug development and clinical pharmacology. Clin Pharmacol Ther. 2013 Jul; 94(1):3-9. PMID: 23778703.
    View in: PubMed115

  69. Giacomini KM47, Balimane PV, Cho SK, Eadon M, Edeki T, Hillgren KM, Huang SM, Sugiyama Y, Weitz D, Wen Y, Xia CQ, Yee SW, Zimdahl H, Niemi M. International Transporter Consortium commentary on clinically important transporter polymorphisms. Clin Pharmacol Ther. 2013 Jul; 94(1):23-6. PMID: 23778707.
    View in: PubMed116

  70. Mushiroda T, Giacomini KM47, Kubo M. Special Section on Pharmacogenomics: recent advances and future directions. J Hum Genet. 2013 Jun; 58(6):305. PMID: 23797326.
    View in: PubMed117

  71. Yee SW, Mefford JA, Singh N, Percival ME, Stecula A, Yang K, Witte JS98, Takahashi A, Kubo M, Matsuda K, Giacomini KM47, Andreadis C. Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia. J Hum Genet. 2013 Jun; 58(6):353-61. PMID: 23677058; PMCID: PMC4068832.
    View in: PubMed118, PubMed Central119

  72. Yee SW, Nguyen AN, Brown C, Savic RM, Zhang Y, Castro RA, Cropp CD, Choi JH, Singh D, Tahara H, Stocker SL, Huang Y, Brett CM99, Giacomini KM47. Reduced renal clearance of cefotaxime in Asians with a low-frequency polymorphism of OAT3 (SLC22A8). J Pharm Sci. 2013 Sep; 102(9):3451-7. PMID: 23649425; PMCID: PMC4151246.
    View in: PubMed120, PubMed Central121

  73. Hillgren KM, Keppler D, Zur AA, Giacomini KM47, Stieger B, Cass CE, Zhang L. Emerging transporters of clinical importance: an update from the International Transporter Consortium. Clin Pharmacol Ther. 2013 Jul; 94(1):52-63. PMID: 23588305.
    View in: PubMed122

  74. Geier EG69, Schlessinger A, Fan H, Gable JE, Irwin JJ123, Sali A124, Giacomini KM47. Structure-based ligand discovery for the Large-neutral Amino Acid Transporter 1, LAT-1. Proc Natl Acad Sci U S A. 2013 Apr 2; 110(14):5480-5. PMID: 23509259; PMCID: PMC3619328.
    View in: PubMed125, PubMed Central126

  75. Dahlin A127, Geier E69, Stocker SL, Cropp CD, Grigorenko E, Bloomer M128, Siegenthaler J129, Xu L, Basile AS, Tang-Liu DD, Giacomini KM47. Gene expression profiling of transporters in the solute carrier and ATP-binding cassette superfamilies in human eye substructures. Mol Pharm. 2013 Feb 4; 10(2):650-63. PMID: 23268600; PMCID: PMC4032224.
    View in: PubMed130, PubMed Central131

  76. Wittwer MB, Zur AA, Khuri N, Kido Y, Kosaka A, Zhang X, Morrissey KM, Sali A124, Huang Y, Giacomini KM47. Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling. J Med Chem. 2013 Feb 14; 56(3):781-95. PMID: 23241029; PMCID: PMC4068829.
    View in: PubMed132, PubMed Central133

  77. Schlessinger A, Khuri N, Giacomini KM47, Sali A124. Molecular modeling and ligand docking for solute carrier (SLC) transporters. Curr Top Med Chem. 2013; 13(7):843-56. PMID: 23578028; PMCID: PMC4056341.
    View in: PubMed134, PubMed Central135

  78. Morrissey KM, Stocker SL, Wittwer MB, Xu L, Giacomini KM47. Renal transporters in drug development. Annu Rev Pharmacol Toxicol. 2013; 53:503-29. PMID: 23140242.
    View in: PubMed136

  79. Chen L, Hong C, Chen EC, Yee SW, Xu L, Almof EU, Wen C, Fujii K, Johns SJ, Stryke D, Ferrin TE137, Simko J, Chen X, Costello JF138, Giacomini KM47. Genetic and epigenetic regulation of the organic cation transporter 3, SLC22A3. Pharmacogenomics J. 2013 Apr; 13(2):110-20. PMID: 22231567; PMCID: PMC3396779.
    View in: PubMed139, PubMed Central140

  80. Stocker SL, Morrissey KM, Yee SW, Castro RA, Xu L, Dahlin A127, Ramirez AH, Roden DM, Wilke RA, McCarty CA, Davis RL, Brett CM99, Giacomini KM47. The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin. Clin Pharmacol Ther. 2013 Feb; 93(2):186-94. PMID: 23267855; PMCID: PMC3671611.
    View in: PubMed141, PubMed Central142

  81. Zamek-Gliszczynski MJ, Hoffmaster KA, Tweedie DJ, Giacomini KM47, Hillgren KM. Highlights from the International Transporter Consortium second workshop. Clin Pharmacol Ther. 2012 Nov; 92(5):553-6. PMID: 23085880.
    View in: PubMed143

  82. Morrissey KM, Wen CC, Johns SJ, Zhang L, Huang SM, Giacomini KM47. The UCSF-FDA TransPortal: a public drug transporter database. Clin Pharmacol Ther. 2012 Nov; 92(5):545-6. PMID: 23085876; PMCID: PMC3974775.
    View in: PubMed144, PubMed Central145

  83. Gong L, Goswami S, Giacomini KM47, Altman RB146, Klein TE. Metformin pathways: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics. 2012 Nov; 22(11):820-7. PMID: 22722338; PMCID: PMC3651676.
    View in: PubMed147, PubMed Central148

  84. Giacomini KM47, Yee SW, Ratain MJ, Weinshilboum RM, Kamatani N, Nakamura Y. Pharmacogenomics and patient care: one size does not fit all. Sci Transl Med. 2012 Sep 26; 4(153):153ps18. PMID: 23019654; PMCID: PMC3963516.
    View in: PubMed149, PubMed Central150

  85. Dubois SG, Geier E69, Batra V, Yee SW, Neuhaus J151, Segal M152, Martinez D, Pawel B, Yanik G, Naranjo A, London WB153, Kreissman S, Baker D, Attiyeh E, Hogarty MD, Maris JM, Giacomini K, Matthay KK77. Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology Group. Int J Mol Imaging. 2012; 2012:250834. PMID: 23050139; PMCID: PMC3463166.
    View in: PubMed154, PubMed Central155

  86. Schlessinger A, Wittwer MB, Dahlin A127, Khuri N, Bonomi M, Fan H, Giacomini KM47, Sali A124. High selectivity of the ?-aminobutyric acid transporter 2 (GAT-2, SLC6A13) revealed by structure-based approach. J Biol Chem. 2012 Nov 2; 287(45):37745-56. PMID: 22932902; PMCID: PMC3488050.
    View in: PubMed156, PubMed Central157

  87. Smith DE, Rowland M, Giacomini KM47, Amidon GL. Dedication to professor Leslie Z. Benet: 50 years of scientific excellence and still going strong! Pharm Res. 2012 Sep; 29(9):2345-53. PMID: 22814901.
    View in: PubMed158

  88. Yee SW, Chen L, Giacomini KM47. The role of ATM in response to metformin treatment and activation of AMPK. Nat Genet. 2012 Apr; 44(4):359-60. PMID: 22456732; PMCID: PMC3359140.
    View in: PubMed159, PubMed Central160

  89. Matsson P, Yee SW, Markova S, Morrissey K, Jenkins G, Xuan J, Jorgenson E, Kroetz DL161, Giacomini KM47. Discovery of regulatory elements in human ATP-binding cassette transporters through expression quantitative trait mapping. Pharmacogenomics J. 2012 Jun; 12(3):214-26. PMID: 21383772; PMCID: PMC3325368.
    View in: PubMed162, PubMed Central163

  90. Ramsey LB, Bruun GH, Yang W, Treviño LR, Vattathil S, Scheet P, Cheng C, Rosner GL, Giacomini KM47, Fan Y, Sparreboom A, Mikkelsen TS, Corydon TJ, Pui CH, Evans WE, Relling MV. Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition. Genome Res. 2012 Jan; 22(1):1-8. PMID: 22147369; PMCID: PMC3246196.
    View in: PubMed164, PubMed Central165

  91. Innocenti F, Owzar K166, Cox NL, Evans P, Kubo M, Zembutsu H, Jiang C, Hollis D, Mushiroda T, Li L, Friedman P, Wang L, Glubb D, Hurwitz H167, Giacomini KM47, McLeod HL, Goldberg RM, Schilsky RL, Kindler HL, Nakamura Y, Ratain MJ. A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303. Clin Cancer Res. 2012 Jan 15; 18(2):577-84. PMID: 22142827; PMCID: PMC3412624.
    View in: PubMed168, PubMed Central169

  92. Mikkelsen TS, Thorn CF, Yang JJ, Ulrich CM, French D170, Zaza G, Dunnenberger HM, Marsh S, McLeod HL, Giacomini K, Becker ML, Gaedigk R, Leeder JS, Kager L, Relling MV, Evans W, Klein TE, Altman RB146. PharmGKB summary: methotrexate pathway. Pharmacogenet Genomics. 2011 Oct; 21(10):679-86. PMID: 21317831; PMCID: PMC3139712.
    View in: PubMed171, PubMed Central172

  93. Choi JH, Yee SW, Ramirez AH, Morrissey KM, Jang GH, Joski PJ, Mefford JA, Hesselson SE, Schlessinger A, Jenkins G, Castro RA, Johns SJ, Stryke D, Sali A, Ferrin TE137, Witte JS98, Kwok PY173, Roden DM, Wilke RA, McCarty CA, Davis RL, Giacomini KM47. A common 5'-UTR variant in MATE2-K is associated with poor response to metformin. Clin Pharmacol Ther. 2011 Nov; 90(5):674-84. PMID: 21956618; PMCID: PMC3329222.
    View in: PubMed174, PubMed Central175

  94. Schlessinger A, Geier E69, Fan H, Irwin JJ123, Shoichet BK64, Giacomini KM47, Sali A124. Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET. Proc Natl Acad Sci U S A. 2011 Sep 20; 108(38):15810-5. PMID: 21885739; PMCID: PMC3179104.
    View in: PubMed176, PubMed Central177

  95. Kido Y, Matsson P, Giacomini KM47. Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. J Med Chem. 2011 Jul 14; 54(13):4548-58. PMID: 21599003; PMCID: PMC3257218.
    View in: PubMed178, PubMed Central179

  96. Picard N, Levoir L, Lamoureux F, Yee SW, Giacomini KM47, Marquet P. Interaction of sirolimus and everolimus with hepatic and intestinal organic anion-transporting polypeptide transporters. Xenobiotica. 2011 Sep; 41(9):752-7. PMID: 21524191.
    View in: PubMed180

  97. More SS, Itsara M, Yang X, Geier EG69, Tadano MK, Seo Y181, Vanbrocklin HF182, Weiss WA183, Mueller S184, Haas-Kogan DA, Dubois SG, Matthay KK77, Giacomini KM47. Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems. Clin Cancer Res. 2011 Apr 15; 17(8):2339-49. PMID: 21421857; PMCID: PMC3247296.
    View in: PubMed185, PubMed Central186

  98. Kim MJ, Skewes-Cox P, Fukushima H, Hesselson S, Yee SW, Ramsey LB, Nguyen L, Eshragh JL, Castro RA, Wen CC, Stryke D, Johns SJ, Ferrin TE137, Kwok PY173, Relling MV, Giacomini KM47, Kroetz DL161, Ahituv N85. Functional characterization of liver enhancers that regulate drug-associated transporters. Clin Pharmacol Ther. 2011 Apr; 89(4):571-8. PMID: 21368754; PMCID: PMC3227682.
    View in: PubMed187, PubMed Central188

  99. Minematsu T, Giacomini KM47. Interactions of tyrosine kinase inhibitors with organic cation transporters and multidrug and toxic compound extrusion proteins. Mol Cancer Ther. 2011 Mar; 10(3):531-9. PMID: 21252289; PMCID: PMC3063525.
    View in: PubMed189, PubMed Central190

  100. Chen L, Xue L, Giacomini KM47, Casida JE. GABAA receptor open-state conformation determines non-competitive antagonist binding. Toxicol Appl Pharmacol. 2011 Feb 1; 250(3):221-8. PMID: 21111751; PMCID: PMC3056339.
    View in: PubMed191, PubMed Central192

  101. Li S, Chen Y, Zhang S, More SS, Huang X, Giacomini KM47. Role of organic cation transporter 1, OCT1 in the pharmacokinetics and toxicity of cis-diammine(pyridine)chloroplatinum(II) and oxaliplatin in mice. Pharm Res. 2011 Mar; 28(3):610-25. PMID: 21104302; PMCID: PMC3040319.
    View in: PubMed193, PubMed Central194

  102. Miller WL195, Agrawal V, Sandee D, Tee MK, Huang N, Choi JH, Morrissey K, Giacomini KM47. Consequences of POR mutations and polymorphisms. Mol Cell Endocrinol. 2011 Apr 10; 336(1-2):174-9. PMID: 21070833; PMCID: PMC4632974.
    View in: PubMed196, PubMed Central197

2001–2010

  1. Yee SW, Gong L, Badagnani I, Giacomini KM47, Klein TE, Altman RB146. SLC19A1 pharmacogenomics summary. Pharmacogenet Genomics. 2010 Nov; 20(11):708-15. PMID: 20811316; PMCID: PMC2956130.
    View in: PubMed198, PubMed Central199

  2. Sandee D, Morrissey K, Agrawal V, Tam HK, Kramer MA, Tracy TS, Giacomini KM47, Miller WL195. Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro. Pharmacogenet Genomics. 2010 Nov; 20(11):677-86. PMID: 20940534.
    View in: PubMed200

  3. Chen L, Pawlikowski B, Schlessinger A, More SS, Stryke D, Johns SJ, Portman MA, Chen E, Ferrin TE137, Sali A124, Giacomini KM47. Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin. Pharmacogenet Genomics. 2010 Nov; 20(11):687-99. PMID: 20859243; PMCID: PMC2976715.
    View in: PubMed201, PubMed Central202

  4. Agrawal V, Choi JH, Giacomini KM47, Miller WL195. Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase. Pharmacogenet Genomics. 2010 Oct; 20(10):611-8. PMID: 20697309; PMCID: PMC2940949.
    View in: PubMed203, PubMed Central204

  5. Shima JE, Komori T, Taylor TR, Stryke D, Kawamoto M, Johns SJ, Carlson EJ, Ferrin TE137, Giacomini KM47. Genetic variants of human organic anion transporter 4 demonstrate altered transport of endogenous substrates. Am J Physiol Renal Physiol. 2010 Oct; 299(4):F767-75. PMID: 20668102; PMCID: PMC2957254.
    View in: PubMed205, PubMed Central206

  6. Chen L, Takizawa M, Chen E, Schlessinger A, Segenthelar J, Choi JH, Sali A, Kubo M, Nakamura S, Iwamoto Y, Iwasaki N, Giacomini KM47. Genetic polymorphisms in organic cation transporter 1 (OCT1) in Chinese and Japanese populations exhibit altered function. J Pharmacol Exp Ther. 2010 Oct; 335(1):42-50. PMID: 20639304; PMCID: PMC2957788.
    View in: PubMed207, PubMed Central208

  7. More SS, Akil O, Ianculescu AG, Geier EG69, Lustig LR, Giacomini KM47. Role of the copper transporter, CTR1, in platinum-induced ototoxicity. J Neurosci. 2010 Jul 14; 30(28):9500-9. PMID: 20631178; PMCID: PMC2949060.
    View in: PubMed209, PubMed Central210

  8. Ahlin G, Chen L, Lazorova L, Chen Y, Ianculescu AG, Davis RL, Giacomini KM47, Artursson P. Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions. Pharmacogenomics J. 2011 Dec; 11(6):400-11. PMID: 20567254.
    View in: PubMed211

  9. More SS, Li S, Yee SW, Chen L, Xu Z, Jablons DM, Giacomini KM47. Organic cation transporters modulate the uptake and cytotoxicity of picoplatin, a third-generation platinum analogue. Mol Cancer Ther. 2010 Apr; 9(4):1058-69. PMID: 20371711; PMCID: PMC3258025.
    View in: PubMed212, PubMed Central213

  10. Yee SW, Chen L, Giacomini KM47. Pharmacogenomics of membrane transporters: past, present and future. Pharmacogenomics. 2010 Apr; 11(4):475-9. PMID: 20350125; PMCID: PMC3234298.
    View in: PubMed214, PubMed Central215

  11. Ianculescu AG, Friesema EC, Visser TJ, Giacomini KM47, Scanlan TS. Transport of thyroid hormones is selectively inhibited by 3-iodothyronamine. Mol Biosyst. 2010 Aug; 6(8):1403-10. PMID: 20358049; PMCID: PMC3257980.
    View in: PubMed216, PubMed Central217

  12. Giacomini KM47, Huang SM, Tweedie DJ, Benet LZ218, Brouwer KL, Chu X, Dahlin A127, Evers R, Fischer V, Hillgren KM, Hoffmaster KA, Ishikawa T, Keppler D, Kim RB, Lee CA, Niemi M, Polli JW, Sugiyama Y, Swaan PW, Ware JA, Wright SH, Yee SW, Zamek-Gliszczynski MJ, Zhang L. Membrane transporters in drug development. Nat Rev Drug Discov. 2010 Mar; 9(3):215-36. PMID: 20190787; PMCID: PMC3326076.
    View in: PubMed219, PubMed Central220

  13. Schlessinger A, Matsson P, Shima JE, Pieper U, Yee SW, Kelly L, Apeltsin L, Stroud RM221, Ferrin TE137, Giacomini KM47, Sali A124. Comparison of human solute carriers. Protein Sci. 2010 Mar; 19(3):412-28. PMID: 20052679; PMCID: PMC2866268.
    View in: PubMed222, PubMed Central223

  14. Huang SM, Zhang L, Giacomini KM47. The International Transporter Consortium: a collaborative group of scientists from academia, industry, and the FDA. Clin Pharmacol Ther. 2010 Jan; 87(1):32-6. PMID: 20019700.
    View in: PubMed224

  15. Kroetz DL161, Yee SW, Giacomini KM47. The pharmacogenomics of membrane transporters project: research at the interface of genomics and transporter pharmacology. Clin Pharmacol Ther. 2010 Jan; 87(1):109-16. PMID: 19940846; PMCID: PMC2923224.
    View in: PubMed225, PubMed Central226

  16. Picard N, Yee SW, Woillard JB, Lebranchu Y, Le Meur Y, Giacomini KM47, Marquet P. The role of organic anion-transporting polypeptides and their common genetic variants in mycophenolic acid pharmacokinetics. Clin Pharmacol Ther. 2010 Jan; 87(1):100-8. PMID: 19890249; PMCID: PMC2884029.
    View in: PubMed227, PubMed Central228

  17. Treviño LR, Shimasaki N, Yang W, Panetta JC, Cheng C, Pei D, Chan D, Sparreboom A, Giacomini KM47, Pui CH, Evans WE, Relling MV. Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects. J Clin Oncol. 2009 Dec 10; 27(35):5972-8. PMID: 19901119; PMCID: PMC2793040.
    View in: PubMed229, PubMed Central230

  18. Kroetz DL161, Ahituv N85, Burchard EG, Guo S231, Sali A124, Giacomini KM47. Institutional Profile: The University of California Pharmacogenomics Center: at the interface of genomics, biological mechanisms and drug therapy. Pharmacogenomics. 2009 Oct; 10(10):1569-76. PMID: 19842929; PMCID: PMC2923222.
    View in: PubMed232, PubMed Central233

  19. Ha Choi J, Wah Yee S, Kim MJ, Nguyen L, Ho Lee J, Kang JO, Hesselson S, Castro RA, Stryke D, Johns SJ, Kwok PY173, Ferrin TE137, Goo Lee M, Black BL234, Ahituv N85, Giacomini KM47. Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1. Pharmacogenet Genomics. 2009 Oct; 19(10):770-80. PMID: 19745787; PMCID: PMC2976711.
    View in: PubMed235, PubMed Central236

  20. Kelly L, Pieper U, Eswar N, Hays FA, Li M, Roe-Zurz Z, Kroetz DL161, Giacomini KM47, Stroud RM221, Sali A124. A survey of integral alpha-helical membrane proteins. J Struct Funct Genomics. 2009 Dec; 10(4):269-80. PMID: 19760129.
    View in: PubMed237

  21. Hesselson SE, Matsson P, Shima JE, Fukushima H, Yee SW, Kobayashi Y, Gow JM, Ha C, Ma B238, Poon A, Johns SJ, Stryke D, Castro RA, Tahara H, Choi JH, Chen L, Picard N, Sjödin E, Roelofs MJ, Ferrin TE137, Myers R, Kroetz DL161, Kwok PY173, Giacomini KM47. Genetic variation in the proximal promoter of ABC and SLC superfamilies: liver and kidney specific expression and promoter activity predict variation. PLoS One. 2009; 4(9):e6942. PMID: 19742321; PMCID: PMC2735003.
    View in: PubMed239, PubMed Central240

  22. McBride BF, Yang T, Liu K, Urban TJ, Giacomini KM47, Kim RB, Roden DM. The organic cation transporter, OCTN1, expressed in the human heart, potentiates antagonism of the HERG potassium channel. J Cardiovasc Pharmacol. 2009 Jul; 54(1):63-71. PMID: 19528813; PMCID: PMC3745652.
    View in: PubMed241, PubMed Central242

  23. Chen Y, Li S, Brown C, Cheatham S, Castro RA, Leabman MK, Urban TJ, Chen L, Yee SW, Choi JH, Huang Y, Brett CM99, Burchard EG, Giacomini KM47. Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin. Pharmacogenet Genomics. 2009 Jul; 19(7):497-504. PMID: 19483665; PMCID: PMC3104496.
    View in: PubMed243, PubMed Central244

  24. Chen Y, Teranishi K, Li S, Yee SW, Hesselson S, Stryke D, Johns SJ, Ferrin TE137, Kwok P173, Giacomini KM47. Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function. Pharmacogenomics J. 2009 Apr; 9(2):127-36. PMID: 19172157; PMCID: PMC2949062.
    View in: PubMed245, PubMed Central246

  25. Tahara H, Yee SW, Urban TJ, Hesselson S, Castro RA, Kawamoto M, Stryke D, Johns SJ, Ferrin TE137, Kwok PY173, Giacomini KM47. Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5). J Pharmacol Exp Ther. 2009 Apr; 329(1):262-71. PMID: 19141711; PMCID: PMC2670604.
    View in: PubMed247, PubMed Central248

  26. Yee SW, Shima JE, Hesselson S, Nguyen L, De Val S, Lafond RJ, Kawamoto M, Johns SJ, Stryke D, Kwok PY173, Ferrin TE137, Black BL234, Gurwitz D, Ahituv N85, Giacomini KM47. Identification and characterization of proximal promoter polymorphisms in the human concentrative nucleoside transporter 2 (SLC28A2). J Pharmacol Exp Ther. 2009 Mar; 328(3):699-707. PMID: 19098160; PMCID: PMC2682268.
    View in: PubMed249, PubMed Central250

  27. Ianculescu AG, Giacomini KM47, Scanlan TS. Identification and characterization of 3-iodothyronamine intracellular transport. Endocrinology. 2009 Apr; 150(4):1991-9. PMID: 19074582; PMCID: PMC2659270.
    View in: PubMed251, PubMed Central252

  28. Li M, Hays FA, Roe-Zurz Z, Vuong L, Kelly L, Ho CM, Robbins RM, Pieper U, O'Connell JD, Miercke LJ, Giacomini KM47, Sali A124, Stroud RM221. Selecting optimum eukaryotic integral membrane proteins for structure determination by rapid expression and solubilization screening. J Mol Biol. 2009 Jan 23; 385(3):820-30. PMID: 19061901; PMCID: PMC2659619.
    View in: PubMed253, PubMed Central254

  29. Miller WL195, Huang N, Agrawal V, Giacomini KM47. Genetic variation in human P450 oxidoreductase. Mol Cell Endocrinol. 2009 Mar 5; 300(1-2):180-4. PMID: 18930113.
    View in: PubMed255

  30. Sorani MD, Manley GT256, Giacomini KM47. Genetic variation in human aquaporins and effects on phenotypes of water homeostasis. Hum Mutat. 2008 Sep; 29(9):1108-17. PMID: 18470935.
    View in: PubMed257

  31. Figg WD, Chau CH, Okita R, Preusch P, Tracy TS, McLeod H, Reed M, Pieper J, Knoell D258, Miller K, Speedie M, Blouin R, Kroboth P258, Koda-Kimble MA258, Taylor P, Cohen J, Giacomini K. Pharm. D. pathways to biomedical research: the National Institutes of Health special conference on pharmacy research. Pharmacotherapy. 2008 Jul; 28(7):821-33. PMID: 18576897.
    View in: PubMed259

  32. Lovejoy KS, Todd RC, Zhang S, McCormick MS, D'Aquino JA, Reardon JT, Sancar A, Giacomini KM47, Lippard SJ. cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects. Proc Natl Acad Sci U S A. 2008 Jul 1; 105(26):8902-7. PMID: 18579768; PMCID: PMC2449337.
    View in: PubMed260, PubMed Central261

  33. Weiss ST262, McLeod HL, Flockhart DA, Dolan ME, Benowitz NL263, Johnson JA, Ratain MJ, Giacomini KM47. Creating and evaluating genetic tests predictive of drug response. Nat Rev Drug Discov. 2008 Jul; 7(7):568-74. PMID: 18587383; PMCID: PMC2682785.
    View in: PubMed264, PubMed Central265

  34. Cropp CD, Yee SW, Giacomini KM47. Genetic variation in drug transporters in ethnic populations. Clin Pharmacol Ther. 2008 Sep; 84(3):412-6. PMID: 18528433; PMCID: PMC2976712.
    View in: PubMed266, PubMed Central267

  35. Sorani MD, Zador Z, Hurowitz E, Yan D, Giacomini KM47, Manley GT256. Novel variants in human Aquaporin-4 reduce cellular water permeability. Hum Mol Genet. 2008 Aug 1; 17(15):2379-89. PMID: 18511455; PMCID: PMC2733814.
    View in: PubMed268, PubMed Central269

  36. Sorani MD, Morabito D, Rosenthal G, Giacomini KM47, Manley GT256. Characterizing the dose-response relationship between mannitol and intracranial pressure in traumatic brain injury patients using a high-frequency physiological data collection system. J Neurotrauma. 2008 Apr; 25(4):291-8. PMID: 18373479.
    View in: PubMed270

  37. Abla N, Chinn LW, Nakamura T, Liu L, Huang CC, Johns SJ, Kawamoto M, Stryke D, Taylor TR, Ferrin TE137, Giacomini KM47, Kroetz DL161. The human multidrug resistance protein 4 (MRP4, ABCC4): functional analysis of a highly polymorphic gene. J Pharmacol Exp Ther. 2008 Jun; 325(3):859-68. PMID: 18364470; PMCID: PMC2612728.
    View in: PubMed271, PubMed Central272

  38. Huang N, Agrawal V, Giacomini KM47, Miller WL195. Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations. Proc Natl Acad Sci U S A. 2008 Feb 5; 105(5):1733-8. PMID: 18230729; PMCID: PMC2234213.
    View in: PubMed273, PubMed Central274

  39. Cropp CD, Komori T, Shima JE, Urban TJ, Yee SW, More SS, Giacomini KM47. Organic anion transporter 2 (SLC22A7) is a facilitative transporter of cGMP. Mol Pharmacol. 2008 Apr; 73(4):1151-8. PMID: 18216183; PMCID: PMC2698938.
    View in: PubMed275, PubMed Central276

  40. Urban TJ, Brown C, Castro RA, Shah N, Mercer R, Huang Y, Brett CM99, Burchard EG, Giacomini KM47. Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentin. Clin Pharmacol Ther. 2008 Mar; 83(3):416-21. PMID: 17609685.
    View in: PubMed277

  41. Shu Y, Brown C, Castro RA, Shi RJ, Lin ET278, Owen RP, Sheardown SA, Yue L, Burchard EG, Brett CM99, Giacomini KM47. Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics. Clin Pharmacol Ther. 2008 Feb; 83(2):273-80. PMID: 17609683; PMCID: PMC2976713.
    View in: PubMed279, PubMed Central280

  42. Wilke RA, Lin DW, Roden DM, Watkins PB, Flockhart D, Zineh I, Giacomini KM47, Krauss RM281. Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat Rev Drug Discov. 2007 Nov; 6(11):904-16. PMID: 17971785; PMCID: PMC2763923.
    View in: PubMed282, PubMed Central283

  43. Urban TJ, Yang C, Lagpacan LL, Brown C, Castro RA, Taylor TR, Huang CC, Stryke D, Johns SJ, Kawamoto M, Carlson EJ, Ferrin TE137, Burchard EG, Giacomini KM47. Functional effects of protein sequence polymorphisms in the organic cation/ergothioneine transporter OCTN1 (SLC22A4). Pharmacogenet Genomics. 2007 Sep; 17(9):773-82. PMID: 17700366.
    View in: PubMed284

  44. Chen Y, Zhang S, Sorani M, Giacomini KM47. Transport of paraquat by human organic cation transporters and multidrug and toxic compound extrusion family. J Pharmacol Exp Ther. 2007 Aug; 322(2):695-700. PMID: 17495125.
    View in: PubMed285

  45. Shu Y, Sheardown SA, Brown C, Owen RP, Zhang S, Castro RA, Ianculescu AG, Yue L, Lo JC, Burchard EG, Brett CM99, Giacomini KM47. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J Clin Invest. 2007 May; 117(5):1422-31. PMID: 17476361; PMCID: PMC1857259.
    View in: PubMed286, PubMed Central287

  46. Altman RB146, Benowitz N263, Gurwitz D, Lunshof J288, Relling M, Lamba J, Wieben E, Mooney S, Giacomini K47, Weiss S262, Johnson JA, McLeod H, Flockhart D, Weinshilboum R, Shuldiner AR, Roden D, Krauss RM281, Ratain M. Genetic nondiscrimination legislation: a critical prerequisite for pharmacogenomics data sharing. Pharmacogenomics. 2007 May; 8(5):519. PMID: 17465717.
    View in: PubMed289

  47. Giacomini KM47, Krauss RM281, Roden DM, Eichelbaum M, Hayden MR, Nakamura Y. When good drugs go bad. Nature. 2007 Apr 26; 446(7139):975-7. PMID: 17460642.
    View in: PubMed290

  48. Giacomini KM47, Brett CM99, Altman RB146, Benowitz NL263, Dolan ME, Flockhart DA, Johnson JA, Hayes DF, Klein T, Krauss RM281, Kroetz DL161, McLeod HL, Nguyen AT, Ratain MJ, Relling MV, Reus V291, Roden DM, Schaefer CA, Shuldiner AR, Skaar T, Tantisira K, Tyndale RF, Wang L, Weinshilboum RM, Weiss ST262, Zineh I. The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin Pharmacol Ther. 2007 Mar; 81(3):328-45. PMID: 17339863.
    View in: PubMed292

  49. Roden DM, Altman RB146, Benowitz NL263, Flockhart DA, Giacomini KM47, Johnson JA, Krauss RM281, McLeod HL, Ratain MJ, Relling MV, Ring HZ, Shuldiner AR, Weinshilboum RM, Weiss ST262. Pharmacogenomics: challenges and opportunities. Ann Intern Med. 2006 Nov 21; 145(10):749-57. PMID: 17116919.
    View in: PubMed293

  50. Zhang S, Lovejoy KS, Shima JE, Lagpacan LL, Shu Y, Lapuk A, Chen Y, Komori T, Gray JW, Chen X, Lippard SJ, Giacomini KM47. Organic cation transporters are determinants of oxaliplatin cytotoxicity. Cancer Res. 2006 Sep 1; 66(17):8847-57. PMID: 16951202; PMCID: PMC2775093.
    View in: PubMed294, PubMed Central295

  51. Urban TJ, Gallagher RC296, Brown C, Castro RA, Lagpacan LL, Brett CM99, Taylor TR, Carlson EJ, Ferrin TE137, Burchard EG, Packman S297, Giacomini KM47. Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5). Mol Pharmacol. 2006 Nov; 70(5):1602-11. PMID: 16931768.
    View in: PubMed298

  52. Owen RP, Badagnani I, Giacomini KM47. Molecular determinants of specificity for synthetic nucleoside analogs in the concentrative nucleoside transporter, CNT2. J Biol Chem. 2006 Sep 8; 281(36):26675-82. PMID: 16840788.
    View in: PubMed299

  53. Badagnani I, Castro RA, Taylor TR, Brett CM99, Huang CC, Stryke D, Kawamoto M, Johns SJ, Ferrin TE137, Carlson EJ, Burchard EG, Giacomini KM47. Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants. J Pharmacol Exp Ther. 2006 Aug; 318(2):521-9. PMID: 16702441.
    View in: PubMed300

  54. Badagnani I, Sorani M, Edwards RH301, Brown C, Castro RA, Huang CC, Stryke D, Kawamoto M, Johns SJ, Carlson EJ, Taylor T, Chan W, De La Cruz M, Ferrin TE137, Burchard EG, Herskowitz I, Kroetz DL161, Giacomini KM47. PharmGKB submission update: VI. PMT submissions of genetic variations in neurotransmitter transporters (SLC6, SLC17, and SLC18) to the PharmGKB network. Pharmacol Rev. 2006 Mar; 58(1):5-6. PMID: 16507879.
    View in: PubMed302

  55. Nguyen TD, Gow JM, Chinn LW, Kelly L, Jeong H, Huang CC, Stryke D, Kawamoto M, Johns SJ, Carlson E, Taylor T, Ferrin TE137, Sali A124, Giacomini KM47, Kroetz DL161. PharmGKB submission update: IV. PMT submissions of genetic variations in ATP-Binding cassette transporters to the PharmGKB network. Pharmacol Rev. 2006 Mar; 58(1):1-2. PMID: 16507877.
    View in: PubMed303

  56. Shu Y, Urban TJ, Leabman MK, Fujita T, Erdman AR, Lagpacan LL, Brown C, Castro RA, Huang CC, Stryke D, Kawamoto M, Johns SJ, Taylor TR, Chan W, De La Cruz M, Carlson EJ, Ferrin TE137, Brett CM99, Burchard EG, Herskowitz I, Kroetz DL161, Giacomini KM47. PharmGKB submission update: V. PMT submissions of genetic variation in SLC22 family transporters. Pharmacol Rev. 2006 Mar; 58(1):3-4. PMID: 16507878.
    View in: PubMed304

  57. Fujita T, Urban TJ, Leabman MK, Fujita K, Giacomini KM47. Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants. J Pharm Sci. 2006 Jan; 95(1):25-36. PMID: 16307453.
    View in: PubMed305

  58. Erdman AR, Mangravite LM, Urban TJ, Lagpacan LL, Castro RA, de la Cruz M, Chan W, Huang CC, Johns SJ, Kawamoto M, Stryke D, Taylor TR, Carlson EJ, Ferrin TE137, Brett CM99, Burchard EG, Giacomini KM47. The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics. Am J Physiol Renal Physiol. 2006 Apr; 290(4):F905-12. PMID: 16291576.
    View in: PubMed306

  59. Owen RP, Lagpacan LL, Taylor TR, De La Cruz M, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE137, Giacomini KM47. Functional characterization and haplotype analysis of polymorphisms in the human equilibrative nucleoside transporter, ENT2. Drug Metab Dispos. 2006 Jan; 34(1):12-5. PMID: 16214850.
    View in: PubMed307

  60. Owen RP, Gray JH, Taylor TR, Carlson EJ, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE137, Giacomini KM47. Genetic analysis and functional characterization of polymorphisms in the human concentrative nucleoside transporter, CNT2. Pharmacogenet Genomics. 2005 Feb; 15(2):83-90. PMID: 15861032.
    View in: PubMed308

  61. Badagnani I, Chan W, Castro RA, Brett CM99, Huang CC, Stryke D, Kawamoto M, Johns SJ, Ferrin TE137, Carlson EJ, Burchard EG, Giacomini KM47. Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3). Pharmacogenomics J. 2005; 5(3):157-65. PMID: 15738947.
    View in: PubMed309

  62. Gray JH, Mangravite LM, Owen RP, Urban TJ, Chan W, Carlson EJ, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE137, Giacomini KM47. Functional and genetic diversity in the concentrative nucleoside transporter, CNT1, in human populations. Mol Pharmacol. 2004 Mar; 65(3):512-9. PMID: 14978229.
    View in: PubMed310

  63. Gray JH, Owen RP, Giacomini KM47. The concentrative nucleoside transporter family, SLC28. Pflugers Arch. 2004 Feb; 447(5):728-34. PMID: 12856181.
    View in: PubMed311

  64. Mangravite LM, Badagnani I, Giacomini KM47. Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidney. Eur J Pharmacol. 2003 Oct 31; 479(1-3):269-81. PMID: 14612157.
    View in: PubMed312

  65. Leabman MK, Giacomini KM47. Estimating the contribution of genes and environment to variation in renal drug clearance. Pharmacogenetics. 2003 Sep; 13(9):581-4. PMID: 12972957.
    View in: PubMed313

  66. Leabman MK, Huang CC, Stryke D, Johns SJ, Kawamoto M, Ferrin TE137, DeYoung J, Taylor TR, De La Cruz M, Herskowitz I, Giacomini KM47. PharmGKB update: I. Genetic variants of the organic cation transporter 2 (OCT2, SLC22A2). Pharmacol Rev. 2003 Sep; 55(3):399. PMID: 12869664.
    View in: PubMed314

  67. Osato DH, Huang CC, Kawamoto M, Johns SJ, Stryke D, Wang J, Ferrin TE137, Herskowitz I, Giacomini KM47. Functional characterization in yeast of genetic variants in the human equilibrative nucleoside transporter, ENT1. Pharmacogenetics. 2003 May; 13(5):297-301. PMID: 12724623.
    View in: PubMed315

  68. Leabman MK, Huang CC, DeYoung J, Carlson EJ, Taylor TR, de la Cruz M, Johns SJ, Stryke D, Kawamoto M, Urban TJ, Kroetz DL161, Ferrin TE137, Clark AG, Risch N73, Herskowitz I, Giacomini KM47. Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc Natl Acad Sci U S A. 2003 May 13; 100(10):5896-901. PMID: 12719533; PMCID: PMC156298.
    View in: PubMed316, PubMed Central317

  69. Mangravite LM, Giacomini KM47. Sorting of rat SPNT in renal epithelium is independent of N-glycosylation. Pharm Res. 2003 Feb; 20(2):319-23. PMID: 12636174.
    View in: PubMed318

  70. Mangravite LM, Xiao G, Giacomini KM47. Localization of human equilibrative nucleoside transporters, hENT1 and hENT2, in renal epithelial cells. Am J Physiol Renal Physiol. 2003 May; 284(5):F902-10. PMID: 12527552.
    View in: PubMed319

  71. Feng B, Dresser MJ, Shu Y, Johns SJ, Giacomini KM47. Arginine 454 and lysine 370 are essential for the anion specificity of the organic anion transporter, rOAT3. Biochemistry. 2001 May 8; 40(18):5511-20. PMID: 11331016.
    View in: PubMed320

  72. Mangravite LM, Lipschutz JH, Mostov KE321, Giacomini KM47. Localization of GFP-tagged concentrative nucleoside transporters in a renal polarized epithelial cell line. Am J Physiol Renal Physiol. 2001 May; 280(5):F879-85. PMID: 11292631.
    View in: PubMed322

  73. Glatt CE, DeYoung JA, Delgado S, Service SK, Giacomini KM47, Edwards RH, Risch N73, Freimer NB. Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes. Nat Genet. 2001 Apr; 27(4):435-8. PMID: 11279528.
    View in: PubMed323

  74. Dresser MJ, Leabman MK, Giacomini KM47. Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters. J Pharm Sci. 2001 Apr; 90(4):397-421. PMID: 11170032.
    View in: PubMed324

  75. Dresser MJ, Gray AT, Giacomini KM47. Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1). J Pharmacol Exp Ther. 2000 Mar; 292(3):1146-52. PMID: 10688634.
    View in: PubMed325

1991–2000

  1. Zhang L, Gorset W, Dresser MJ, Giacomini KM47. The interaction of n-tetraalkylammonium compounds with a human organic cation transporter, hOCT1. J Pharmacol Exp Ther. 1999 Mar; 288(3):1192-8. PMID: 10027858.
    View in: PubMed326

  2. Dresser MJ, Zhang L, Giacomini KM47. Molecular and functional characteristics of cloned human organic cation transporters. Pharm Biotechnol. 1999; 12:441-69. PMID: 10742984.
    View in: PubMed327

  3. Zhang L, Brett CM99, Giacomini KM47. Role of organic cation transporters in drug absorption and elimination. Annu Rev Pharmacol Toxicol. 1998; 38:431-60. PMID: 9597162.
    View in: PubMed328

  4. Wang J, Su SF, Dresser MJ, Schaner ME, Washington CB, Giacomini KM47. Na(+)-dependent purine nucleoside transporter from human kidney: cloning and functional characterization. Am J Physiol. 1997 Dec; 273(6 Pt 2):F1058-65. PMID: 9435697.
    View in: PubMed329

  5. Giacomini KM47. Membrane transporters in drug disposition. J Pharmacokinet Biopharm. 1997 Dec; 25(6):731-41. PMID: 9697080.
    View in: PubMed330

  6. Ramanathan VK, Brett CM99, Giacomini KM47. Na+-dependent gamma-aminobutyric acid (GABA) transport in the choroid plexus of rabbit. Biochim Biophys Acta. 1997 Nov 13; 1330(1):94-102. PMID: 9375816.
    View in: PubMed331

  7. Wang J, Schaner ME, Thomassen S, Su SF, Piquette-Miller M, Giacomini KM47. Functional and molecular characteristics of Na(+)-dependent nucleoside transporters. Pharm Res. 1997 Nov; 14(11):1524-32. PMID: 9434270.
    View in: PubMed332

  8. Schaner ME, Wang J, Zevin S, Gerstin KM, Giacomini KM47. Transient expression of a purine-selective nucleoside transporter (SPNTint) in a human cell line (HeLa). Pharm Res. 1997 Oct; 14(10):1316-21. PMID: 9358542.
    View in: PubMed333

  9. Chun JK, Zhang L, Piquette-Miller M, Lau E, Tong LQ, Giacomini KM47. Characterization of guanidine transport in human renal brush border membranes. Pharm Res. 1997 Jul; 14(7):936-41. PMID: 9244153.
    View in: PubMed334

  10. Zhang L, Dresser MJ, Chun JK, Babbitt PC335, Giacomini KM47. Cloning and functional characterization of a rat renal organic cation transporter isoform (rOCT1A). J Biol Chem. 1997 Jun 27; 272(26):16548-54. PMID: 9195965.
    View in: PubMed336

  11. Chun JK, Piquette-Miller M, Zhang L, Giacomini KM47. Expression of human polyspecific renal organic cation transport activity in Xenopus laevis oocytes. J Pharm Sci. 1997 Jun; 86(6):753-5. PMID: 9188060.
    View in: PubMed337

  12. Ramanathan VK, Chung SJ, Giacomini KM47, Brett CM99. Taurine transport in cultured choroid plexus. Pharm Res. 1997 Apr; 14(4):406-9. PMID: 9144722.
    View in: PubMed338

  13. Ramanathan VK, Hui AC, Brett CM99, Giacomini KM47. Primary cell culture of the rabbit choroid plexus: an experimental system to investigate membrane transport. Pharm Res. 1996 Jun; 13(6):952-6. PMID: 8792439.
    View in: PubMed339

  14. Chung SJ, Ramanathan VK, Brett CM99, Giacomini KM47. Saturable disposition of taurine in the rat cerebrospinal fluid. J Pharmacol Exp Ther. 1996 Feb; 276(2):676-82. PMID: 8632336.
    View in: PubMed340

  15. Gutierrez MM, Brett CM99, Giacomini KM47. Isolated renal brush border and basolateral membrane vesicles and cultured renal cells. Pharm Biotechnol. 1996; 8:193-210. PMID: 8791811.
    View in: PubMed341

  16. Washington CB, Giacomini KM47. Mechanisms of nucleobase transport in rabbit choroid plexus. Evidence for a Na(+)-dependent nucleobase transporter with broad substrate selectivity. J Biol Chem. 1995 Sep 29; 270(39):22816-9. PMID: 7559412.
    View in: PubMed342

  17. Washington CB, Brett CM99, Wu X, Giacomini KM47. The effect of N-ethylmaleimide on the Na(+)-dependent nucleoside transporter (N3) in rabbit choroid plexus. J Pharmacol Exp Ther. 1995 Jul; 274(1):110-4. PMID: 7616386.
    View in: PubMed343

  18. Lubic SP, Giacomini KM47, Giacomini JC. The effects of modulation of calcium influx through the voltage-sensitive calcium channel on cardiomyocyte hypertrophy. J Mol Cell Cardiol. 1995 Mar; 27(3):917-25. PMID: 7602609.
    View in: PubMed344

  19. Lubic SP, Giacomini KM47, Giacomini JC. Increased 1,4-dihydropyridine binding sites in serum-stimulated cardiomyocyte hypertrophy. J Pharmacol Exp Ther. 1994 Aug; 270(2):697-701. PMID: 8071861.
    View in: PubMed345

  20. Wu X, Giacomini KM47. Expression of the choroid plexus sodium-nucleoside cotransporter (N3) in Xenopus laevis oocytes. Biochem Pharmacol. 1994 Jul 19; 48(2):432-4. PMID: 7519856.
    View in: PubMed346

  21. Chung SJ, Ramanathan V, Giacomini KM47, Brett CM99. Characterization of a sodium-dependent taurine transporter in rabbit choroid plexus. Biochim Biophys Acta. 1994 Jul 13; 1193(1):10-6. PMID: 8038178.
    View in: PubMed347

  22. Giacomini KM47, Markovich D, Werner A, Biber J, Wu X, Murer H. Expression of a renal Na(+)-nucleoside cotransport system (N2) in Xenopus laevis oocytes. Pflugers Arch. 1994 Jun; 427(3-4):381-3. PMID: 7521031.
    View in: PubMed348

  23. Wu X, Gutierrez MM, Giacomini KM47. Further characterization of the sodium-dependent nucleoside transporter (N3) in choroid plexus from rabbit. Biochim Biophys Acta. 1994 Apr 20; 1191(1):190-6. PMID: 8155674.
    View in: PubMed349

  24. Ott RJ, Chan JK, Ramanathan VK, Hui AC, Giacomini KM47. Effect of phenylisothiocyanate on organic cation transport in opossum kidney cells. J Pharmacol Exp Ther. 1994 Apr; 269(1):204-8. PMID: 8169826.
    View in: PubMed350

  25. Gutierrez MM, Giacomini KM47. Substrate selectivity, potential sensitivity and stoichiometry of Na(+)-nucleoside transport in brush border membrane vesicles from human kidney. Biochim Biophys Acta. 1993 Jul 4; 1149(2):202-8. PMID: 8323939.
    View in: PubMed351

  26. Wu X, Hui AC, Giacomini KM47. Formycin B elimination from the cerebrospinal fluid of the rat. Pharm Res. 1993 Apr; 10(4):611-5. PMID: 8483848.
    View in: PubMed352

  27. Brett CM99, Washington CB, Ott RJ, Gutierrez MM, Giacomini KM47. Interaction of nucleoside analogues with the sodium-nucleoside transport system in brush border membrane vesicles from human kidney. Pharm Res. 1993 Mar; 10(3):423-6. PMID: 8464817.
    View in: PubMed353

  28. Hayes K, Morgan B, Giacomini K47, Dockal S. . . Caring for the community. Caring. 1993; 1(12):38-42.

  29. Wu X, Yuan G, Brett CM, Hui AC, Giacomini KM47. Sodium-dependent nucleoside transport in choroid plexus from rabbit. Evidence for a single transporter for purine and pyrimidine nucleosides. J Biol Chem. 1992 May 5; 267(13):8813-8. PMID: 1315741.
    View in: PubMed354

  30. Gutierrez MM, Brett CM, Ott RJ, Hui AC, Giacomini KM47. Nucleoside transport in brush border membrane vesicles from human kidney. Biochim Biophys Acta. 1992 Mar 23; 1105(1):1-9. PMID: 1567888.
    View in: PubMed355

  31. Whittico MT, Hui AC, Giacomini KM47. Preparation of brush border membrane vesicles from bovine choroid plexus. J Pharmacol Methods. 1991 May; 25(3):215-27. PMID: 1647471.
    View in: PubMed356

1981–1990

  1. Ott RJ, Hai AC, Giacomini KM47. Mechanisms of interactions between organic anions and the organic cation transporter in renal brush border membrane vesicles. Biochem Pharmacol. 1990 Aug 1; 40(3):659-61. PMID: 2143380.
    View in: PubMed357

  2. Boyd RA, Chin SK, Don-Pedro O, Verotta D, Sheiner LB, Williams RL, Giacomini KM47. The pharmacokinetics and pharmacodynamics of diltiazem and its metabolites in healthy adults after a single oral dose. Clin Pharmacol Ther. 1989 Oct; 46(4):408-19. PMID: 2791444.
    View in: PubMed358

  3. Chin SK, Hui AC, Giacomini KM47. High-performance liquid chromatographic determination of the enantiomers of beta-adrenoceptor blocking agents in biological fluids. II. Studies with atenolol. J Chromatogr. 1989 Apr 14; 489(2):438-45. PMID: 2568994.
    View in: PubMed359

  4. Giacomini KM47, Hsyu PH, Gisclon LG. Renal transport of drugs: an overview of methodology with application to cimetidine. Pharm Res. 1988 Aug; 5(8):465-71. PMID: 3072557.
    View in: PubMed360

  5. Gisclon L, Wong FM, Giacomini KM47. Cimetidine transport in isolated luminal membrane vesicles from rabbit kidney. Am J Physiol. 1987 Jul; 253(1 Pt 2):F141-50. PMID: 3605344.
    View in: PubMed361

  6. Hsyu PH, Giacomini KM47. Essential tyrosine residues in transport of organic cations in renal BBMV. Am J Physiol. 1987 Jun; 252(6 Pt 2):F1065-72. PMID: 2954470.
    View in: PubMed362

  7. Hsyu PH, Giacomini KM47. The pH gradient-dependent transport of organic cations in the renal brush border membrane. Studies with acridine orange. J Biol Chem. 1987 Mar 25; 262(9):3964-8. PMID: 2951380.
    View in: PubMed363

  8. Giacomini KM47, Nelson WL, Pershe RA, Valdivieso L, Turner-Tamiyasu K, Blaschke TF. In vivo interaction of the enantiomers of disopyramide in human subjects. J Pharmacokinet Biopharm. 1986 Aug; 14(4):335-56. PMID: 3772736.
    View in: PubMed364

  9. Giacomini JC, Nelson WL, Theodore L, Wong FM, Rood D, Giacomini KM47. The pharmacokinetics and pharmacodynamics of d- and dl-verapamil in rabbits. J Cardiovasc Pharmacol. 1985 May-Jun; 7(3):469-75. PMID: 2410676.
    View in: PubMed365

  10. Giacomini KM47, Massoud N, Wong FM, Giacomini JC. Decreased binding of verapamil to plasma proteins in patients with liver disease. J Cardiovasc Pharmacol. 1984 Sep-Oct; 6(5):924-8. PMID: 6209501.
    View in: PubMed366

  11. Giacomini KM47, Wong FM, Tozer TN. Correction for Volume Shift during Equilibrium Dialysis by Measurement of Protein Concentration. Pharm Res. 1984 Jul; 1(4):179-81. PMID: 24277288.
    View in: PubMed367

  12. Smith GA, Giacomini KM47, Smith CT, Gregory PB, Robinson WS, Merigan TC368, Blaschke TF. High-performance liquid chromatographic analysis of hypoxanthine arabinoside in plasma. J Chromatogr. 1984 May 11; 307(2):410-5. PMID: 6203924.
    View in: PubMed369

  13. Schulz P, Abang A, Giacomini JC, Blaschke TF, Giacomini KM47. Effect of heparin on the red blood cell-to-plasma concentration ratio of diphenylhydantoin and prazosin. Ther Drug Monit. 1983; 5(4):497-9. PMID: 6659020.
    View in: PubMed370

  14. Smith GA, Schulz P, Giacomini KM47, Blaschke TF. High-pressure liquid chromatographic determination of amitriptyline and its major metabolites in human whole blood. J Pharm Sci. 1982 May; 71(5):581-3. PMID: 7097507.
    View in: PubMed371

  15. Giacomini KM47, Swezey SE, Turner-Tamiyasu K, Blaschke TF. The effect of saturable binding to plasma proteins on the pharmacokinetic properties of disopyramide. J Pharmacokinet Biopharm. 1982 Feb; 10(1):1-14. PMID: 7069575.
    View in: PubMed372

  16. Nelson WL, Sneed CK, Giacomini KM47, Giacomini JC, Stauss J, Blaschke TF, Cox BM. Synthesis and anticholinergic properties of the enantiomers of 4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide, the mono-N-dealkylated metabolite of disopyramide. J Med Chem. 1981 May; 24(5):614-7. PMID: 7241519.
    View in: PubMed373

  17. Giacomini KM47, Roberts SM, Levy G. Evaluation of methods for producing renal dysfunction in rats. J Pharm Sci. 1981 Feb; 70(2):117-21. PMID: 7205211.
    View in: PubMed374

1978–1980

  1. Giacomini KM47, Giacomini JC, Blaschke TF. Absence of effect of heparin on the binding of prazosin and phenytoin to plasma proteins. Biochem Pharmacol. 1980 Dec; 29(24):3337-40. PMID: 7213407.
    View in: PubMed375

  2. Giacomini KM47, Giacomini JC, Swezey SE, Harrison DC, Nelson WL, Burke TR, Blaschke TF. The stereoselective disposition of disopyramide in the dog. J Cardiovasc Pharmacol. 1980 Nov-Dec; 2(6):825-32. PMID: 6160331.
    View in: PubMed376

  3. Giacomini KM47, Swezey SE, Giacomini JC, Blaschke TF. Administration of heparin causes in vitro release of non-esterified fatty acids in human plasma. Life Sci. 1980 Sep 1; 27(9):771-80. PMID: 7412503.
    View in: PubMed377

  4. Giacomini KM47, Gibson TP, Levy G. Plasma protein binding of d-propoxyphene in normal subjects and anephric patients. J Clin Pharmacol. 1978 Feb-Mar; 18(2-3):106-9. PMID: 624774.
    View in: PubMed378

  5. Soles C, Giacomini KM47, Roberts SM, Giacomini JC. Soles C, Giacomini KM47, Roberts SM, Giacomini JC. . A Convenient Method for Repetitive Blood Sampling in the Dog. J. Pharmacol. Meth. 1978; (1):259-261.